Jesús Fortún

A Phase I/IIa Prospective, Randomized, Open-Label Study on the Safety and Efficacy of Nebulized Liposomal Amphotericin for Invasive Pulmonary Aspergillosis

P. Martín-Dávila, C. Soriano, E. Gómez-García de la Pedrosa, 2024, Journal of fungi.

Costs and resource utilization patterns in surgical site infections: A pre-COVID-19 perspective from France, Germany, Spain, and the United Kingdom.

A. Galar, B. Liss, J. Salmanton-García, 2024, The Journal of hospital infection.

Isavuconazole Versus Voriconazole as the First-line Therapy for Solid Organ Transplant Recipients With Invasive Aspergillosis: Comparative Analysis of 2 Multicenter Cohort Studies.

P. Martín-Dávila, A. Illaro, M. Valerio, 2024, Transplantation.

Safety and effectiveness of isavuconazole in real-life non-neutropenic patients.

P. Martín-Dávila, I. Ruiz-Camps, C. Gudiol, 2024, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Length of hospital and intensive care unit stay in patients with invasive candidiasis and/or candidemia treated with rezafungin: a pooled analysis of two randomised controlled trials

T. Sandison, J. Pullman, Peter G. Pappas, 2024, Critical care.

Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update.

P. Martín-Dávila, J. Sánchez-Céspedes, M. Valerio, 2024, Transplantation reviews.